# Lincoln Pharmaceuticals Ltd (LINCOLN)
> Exchange: NSE | Sector: Pharma | ISIN: 

## Price
Current Price: ₹719.15
Day Change: -2.04%
52W High: ₹731.5
52W Low: ₹439.95
Market Cap: ₹1,292 Cr

## Valuation
P/E: 14.71
P/B: 1.8
EPS: ₹43.86
Book Value: ₹357.45
Dividend Yield: 0%

## Returns
1Y Return: 45.33%

## Profitability
ROE: 0%
ROCE: 15.06%
Debt/Equity: 0
Revenue Growth: 13.5%
Profit Growth: 37.7%
EBITDA Margin: 15.51%
Operating Margin: 11.95%

## About
Lincoln Pharmaceuticals Ltd is a Drug Manufacturers - Specialty & Generic company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Drug Manufacturers - Specialty & Generic
Sub Industry: Unknown

## Business Model
Overview: Lincoln Pharmaceuticals Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Drug Manufacturers - Specialty & Generic. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: Compliances-Reg.24(A)-Annual Secretarial Compliance
- Announcement: Announcement under Regulation 30 (LODR)-Newspaper Publication
- BSE Filing: Compliances-Reg.24(A)-Annual Secretarial Compliance

## Access
Current tier: anonymous
More history: Register free to see 9 more years.

## Data Freshness
Quote Updated: 2026-05-25T20:00:13.927Z
Price History Updated: 2026-05-25T05:33:13.428Z
Latest Price History Date: 2026-05-24
Technicals Updated: 2026-05-25T05:33:13.428Z
Quant Updated: 2026-05-25T05:33:13.428Z
Sentiment Updated: 2026-05-25T05:33:13.428Z
Financials Status: current
Financials Updated: 2026-05-18T18:31:32.091Z
Financials Last Attempt: 2026-05-18T18:31:32.091Z
Financials Provider Tried: yahoo
Latest P&L Period: FY25
Latest Balance Sheet Period: FY25
Latest Cash Flow Period: FY25

## P&L (Mar 2015)
Revenue: ₹210 Cr
Operating Profit: ₹20 Cr (OPM 10%)
Net Profit: ₹10 Cr
Tax: ₹12 Cr

## Annual P&L History
Mar 2015: Rev ₹210Cr | PAT ₹10Cr | OPM 10%
Mar 2016: Rev ₹266Cr | PAT ₹15Cr | OPM 10%
Mar 2017: Rev ₹400Cr | PAT ₹24Cr | OPM 10%

## Balance Sheet (Mar 2015)
Total Assets: ₹260 Cr
Total Liabilities: ₹260 Cr
Borrowings: ₹68 Cr
Cash: ₹undefined Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Mahendrabhai Gulabdas Patel B.A, LLB, MD & Whole Time Director
- Darshit Ashvinkumar Shah, Chief Financial Officer
- Trusha Kashish Shah, Company Secretary & Compliance Officer
- Ashish Rajnikant Patel, Whole Time Director
- Hashmukhbhai Ishwarlal Patel B.sc., Whole Time Director

---
Source: rupiya.io/stocks/lincoln
Disclaimer: For research and education only. Not investment advice.